Identify and compare virus-specific antibody epitope recognition of different human coronavirus spike protein antigens in a single assay with the new PEPperCHIP® Pan-Corona Spike Protein Microarray. The chip contains the spike proteins of all seven human coronaviruses (SARS-CoV-2, SARS-CoV, MERS-CoV, HCoV-HKU1, HCoV-OC43, HCoV-NL63, and HCoV-229E) translated into 4,564 individual peptides for a multiplexed epitope mapping.
Screen purified antibodies, human or animal sera for coronavirus-specific spike protein antigen recognition. Analyze the cross-reactivity of diagnostic and therapeutic antibodies or compare patient-specific antibody response profiles for immunity or seroconversion monitoring.
Applications :
Serum antibody fingerprint analysis of IgG, IgM, and IgA antibody responses on the epitope level for IVD test development.
Immune monitoring of antibody responses in SARS-CoV-2 vaccination trials.
Epitope analysis of prognostic or neutralizing antibodies in patient sera for vaccine optimization and development.
Epitope identification and characterization of anti-SARS-CoV-2 antibodies.
Fig.1. Antibody fingerprint or cross-reactivity analysis workflow using the PEPperCHIP® Pan-Corona Spike Protein Microarray. Spike protein sequences of 7 human coronaviruses are translated into overlapping peptides and printed onto glass slides. Antibody samples, patient or animal sera are incubated on the chip followed by antibody binding to the corresponding spike protein epitopes. The resulting epitope profiles can be compared across different samples to determine antibody specificity and sensitivity, or to identify coronavirus-specific target sequences for the development of diagnostic or therapeutic antibodies.
The new PEPperCHIP® Pan-Corona Spike Protein Microarray chip contains a single peptide array and is compatible with a 3/1 well PEPperCHIP® Incubation Tray. Each chip produced comes with HA and polio assay control peptide spots.
Further Reading :
SARS-CoV-2 proteome-wide analysis revealed significant epitope signatures in COVID-19 patients.
Tatjana Schwarz, Kirsten Heiss, Yuvaraj Mahendran, Fiordiligie Casilag, Florian Kurth, Leif Sander, Clemens-Martin Wendtner, Manuela A. Hoechstetter, Marcel A. Müller, Renate Sekul, Christian Drosten, Volker Stadler and Victor M. Corman. Front. Immunol. [https://www.frontiersin.org/articles/10.3389/fimmu.2021.629185/abstract]
SARS-CoV-2 Spike Protein Arrested in the Closed State Induces Potent Neutralizing Responses.
George W. Carnell, Katarzyna A. Ciazynska, David A. Wells, Xiaoli Xiong, Ernest T. Aguinam, Stephen H. McLaughlin, Donna Mallery. Preprint. Immunology, 14. January 2021. [doi.org/10.1101/2021.01.14.426695]
SARS-CoV-2 Epitope Mapping on Microarrays Highlights Strong Immune-Response to N Protein Region.
Angelo Musicò, Roberto Frigerio, Alessandro Mussida, Luisa Barzon, Alessandro Sinigaglia, Silvia Riccetti, Federico Gobbi. Vaccines 9, Nr. 1 (11. January 2021): 35.[doi.org/10.3390/vaccines9010035]
Recent Advances in the Diagnosis of COVID-19: A Bird’s Eye View.
Bhawna Sharma, Mohd FardeenHusain Shahanshah, Sanjay Gupta, and Vandana Gupta. Expert Review of Molecular Diagnostics, 10. January 2021, 14737159.2021.1874354.[doi.org/10.1080/14737159.2021.1874354]
Generation of Chicken IgY against SARS-COV-2 Spike Protein and Epitope Mapping.
Yan Lu, Yajun Wang, Zhen Zhang, Jingliang Huang, Meicun Yao, Guobin Huang, Yuanyuan Ge, et al. Published by Juraj Ivanyi. Journal of Immunology Research 2020 (16. October 2020): 1–8.[doi.org/10.1155/2020/9465398]
Rapid Response to Pandemic Threats: Immunogenic Epitope Detection of Pandemic Pathogens for Diagnostics and Vaccine Development Using Peptide Microarrays.
Kirsten Heiss, Jasmin Heidepriem, Nico Fischer, Laura K Weber, Christine Dahlke, Thomas Jaenisch, und Felix F Loeffler. Journal of Proteome Research, 5. September 2020 [doi.org/10.1021/acs.jproteome.0c00484]
Molecular and Serological Tests for COVID-19. A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics.
Kubina, Robert, und Arkadiusz Dziedzic. Diagnostics 10, Nr. 6 (26. June 2020): 434. [doi.org/10.3390/diagnostics10060434]
Distinct Early IgA Profile May Determine Severity of COVID-19 Symptoms: An Immunological Case Series.
Dahlke, Christine, Jasmin Heidepriem, Robin Kobbe, Rene Santer, Till Koch, Anahita Fathi, My L. Ly, et al. Preprint. Infectious Diseases (except HIV/AIDS), April 17, 2020 [doi.org/10.1101/2020.04.14.20059733]
IgG and IgA Antibody Profiling with the PEPperCHIP® Infectious Disease Epitope Microarray. (Application note)
Discovery of serotype-specific epitope biomarkers for the diagnosis of Dengue virus infections. (Poster)
Profiling epitope-specific antibody responses against malaria utilizing high-density peptide arrays. (Poster)